GLP-1 Weight Loss: The Challenge of Sustained Results
A study of 1.2M patients reveals 58% regain weight after stopping GLP-1 drugs like Wegovy & Ozempic. Highlights the challenge of sustained weight loss and the need for chronic management.
-
-
Emotional Overeating: A GLP-1 Drug Efficacy Challenge
New research reveals GLP-1 weight loss drugs may be less effective for emotional overeaters, highlighting the need for integrated behavioral and pharmacological treatments.
